# Immunoinflammatory Regulation of Esketamine in Septic Patients

> **NCT04843982** · PHASE4 · RECRUITING · sponsor: **Union Hospital, Tongji Medical College, Huazhong University of Science and Technology** · enrollment: 100 (estimated)

## Conditions studied

- Esketamine
- Sepsis
- Inflammatory Response
- Immunosuppression

## Interventions

- **DRUG:** Esketamine hydrochloride

## Key facts

- **NCT ID:** NCT04843982
- **Lead sponsor:** Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-07-28
- **Primary completion:** 2026-10-30
- **Final completion:** 2026-10-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04843982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04843982, "Immunoinflammatory Regulation of Esketamine in Septic Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04843982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*